SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3071% below fair value
$2.91−0.30 (-9.35%)
Close on Nov 16, 2026Market cap $28.95MP/E –Yield –
Scynexis gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2014 it was 284.9%, against 3.3% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | 284.9% | +281.6 |
| FY2013 | Dec 31, 2013 | 3.3% | – |
See a number that looks wrong?